Evolution of Lysosomal Proteins

  • Mark Carroll
Conference paper
Part of the NATO ASI Series book series (NSSA, volume 150)


Many of us who have studied lysosomal proteins have an interest in defining the molecular cause of one or other lipid storage disease. The pathology associated with the disordered state can provide considerable insights into the normal process. What we now have, in the form of recombinant DNA techniques, is a tool that can illuminate the structure of the proteins involved in lysosomal lipid catabolism, both in the normal and the disease state. This review considers various aspects of the structure and function of these lipid-metabolising enzymes. The theme running through it is the way in which such proteins are related, with the implication that there may be genetically based links of which we are not yet aware. Or, what one might call, the evolution of lysosomal proteins.


Lysosomal Enzyme Beta Subunit Acid Hydrolase Metachromatic Leukodystrophy Lysosomal Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Artymiuk, P.J., Blake, C.C.F. & Sippel, A.E., 1981, Genes pieced together-exonsdeI ineate homologous structures of diverged lysozymes, Nature, 290: 287.PubMedCrossRefGoogle Scholar
  2. Brew, K., Vanaman, T.C. & Hill, R.L., 1968, The role of a Ipha-I acta Ibumin and the A protein in lactose synthetase, Proc. Nat. Acad. Sci. USA, 59:491.PubMedCrossRefGoogle Scholar
  3. Carroll, M. & Robinson, D., 1974, A low-molecular weight protein crossreacting with human liver N-acetyI-beta-D-gIucosaminidase, Biochem. J., 137:217.Google Scholar
  4. Conzelmann, E., Burg, J., Stephan, G. & Sandhoff, K., 1982, Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal galnglioside GM2, Eur. J. Biochem. 123:455.PubMedCrossRefGoogle Scholar
  5. D’Azzo, A., Hoogeveen, A., Reuser, A. J. J., Robinson, D. & Galjaard, H., 1982, Molecular defect in combined beta-gaIactosidase and neuraminidase deficiency in man, Proc. Nat. Acad. Sci. USA. 79:4534.Google Scholar
  6. Dean, R.T., 1977, “Lysosomes”,p.12, Edward Arnold, London.Google Scholar
  7. Geiger, B. & Arnon, R., 1976, Chemical characterisat ion and subunit structure of human N-acetyIhexosaminisases A and B, Biochemistry, 15:3484.Google Scholar
  8. Inui, K., Emmett, M. & Wenger, D.A., 1983, Immunological evidence for a deficiency in an activator protein for sulphatide sulphatase in a variant form of metachromatic leukodystrophy, Proc. Nat. Acad. Sci. USA. 80:3074.PubMedCrossRefGoogle Scholar
  9. Kaplan, A., Fischer, D., Achard, D. & Sly, W., 1977, PhosphohexosyI recognition is a general characteristic of pinocytosis of lysosomal glycosidases by human fibroblasts, J.CI in.Invest. 60: 1088.Google Scholar
  10. Leroy, J.G., Ho, M.W., MacBrinn, M.C., Zielke, K., Jacobs, J. & O’Brien, J. 1972, I-cell disease: biochemical studies, Pediat. Res. 16:752.Google Scholar
  11. Myerowitz, R., Pickarz, R., Neufeld, E.F., Shows, T.B. & Suzuki, K., 1985, Human beta-hexosaminidase a Ipha-chain:coding sequence and homology with the beta-chain, Proc. Nat. Acad. Sci. USA. 82:7830.Google Scholar
  12. O’Dowd, B., Quan, F., Willard, H., Lamhonwak, A.M., Korneluk, R., Lowden, Gravel,R.A. & Mahuran, D., 1985, Isolation of cDNA clones coding for the beta-subunit of human beta-hexosaminisase, Proc. Nat. Acad. Sci. USA. 82:1184.Google Scholar
  13. Robinson, D. & Carroll, M., 1972, Tay-Sachs disease: interreIation of hexosaminisases A and B, Lancet 1: 322.Google Scholar
  14. Rupley, J.A. & Gates, V., 1967, Studies on the enzymic activity of lysozyme Proc. Nat. Acad. Sci. USA. 57:496.Google Scholar
  15. Stirling, J. L., 1974, NNf-diacetyIchitobiase activity in Tay-Sachs disease and Sandhoff’s disease. Biochem. J. 141:597.Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Mark Carroll
    • 1
  1. 1.Biochemistry DepartmentLondon Hospital Medical CollegeLondonUK

Personalised recommendations